Profil
Richard C.
Duke was the founder of GlobeImmune, Inc., founded in 1995, where the title held was President & Chief Executive Officer from 1995 to 2013.
Dr. Duke is the founder of ApopLogic Pharmaceuticals, Inc., founded in 2006, where the title held is President & Chief Executive Officer.
Dr. Duke is also the founder of Colorado Institute For Drug Device & Diagnostic Development.
Dr. Duke is currently Chairman & Chief Executive Officer at MenoGenix, Inc. Dr. Duke is currently Associate Professor at The University of Colorado.
Former positions include Chairman & Chief Executive Officer at Peptivir, Inc. and Director at Sierra Neuropharmaceuticals, Inc. Education includes an undergraduate degree from McGill University in 1978, a graduate degree from McGill University in 1981, and a doctorate from The University of Colorado in 1985.
Postes actifs de Richard Duke
| Sociétés | Poste | Début |
|---|---|---|
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ApopLogic Pharmaceuticals, Inc.
ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Directeur Général | 01/01/2006 |
MenoGenix, Inc.
MenoGenix, Inc. BiotechnologyHealth Technology Develops drugs for breast and prostate cancer | Directeur Général | - |
Anciens postes connus de Richard Duke
| Sociétés | Poste | Fin |
|---|---|---|
Colorado Institute For Drug Device & Diagnostic Development
Colorado Institute For Drug Device & Diagnostic Development Medical/Nursing ServicesHealth Services Provides health maintenance services | Fondateur | - |
Sierra Neuropharmaceuticals, Inc.
Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Directeur/Membre du Conseil | - |
Peptivir, Inc.
Peptivir, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops synthetic peptide-based vaccine platform for the prevention of viral diseases | Directeur Général | - |
| GLOBEIMMUNE, INC. | Fondateur | - |
Formation de Richard Duke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
GlobeImmune, Inc.
GlobeImmune, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutic products for cancer and infectious diseases | Health Technology |
Sierra Neuropharmaceuticals, Inc.
Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
ApopLogic Pharmaceuticals, Inc.
ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Peptivir, Inc.
Peptivir, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops synthetic peptide-based vaccine platform for the prevention of viral diseases | Health Technology |
MenoGenix, Inc.
MenoGenix, Inc. BiotechnologyHealth Technology Develops drugs for breast and prostate cancer | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colorado Institute For Drug Device & Diagnostic Development
Colorado Institute For Drug Device & Diagnostic Development Medical/Nursing ServicesHealth Services Provides health maintenance services | Health Services |
















